Women can use ‘reversible contraceptive’ without increased HIV risk — WHO

VVF operation in a Nigerian clinic
VVF operation in a Nigerian clinic Photo: Leadership

The World Health Organisation (WHO) has said women can use ‘reversible contraception’, including progestogen-only injectables, implants and intrauterine devices (IUDs), without an increased risk of HIV infection.

This follows the revision of its guidelines on contraceptive use.

In a statement published on its website, the organisation, however, said these contraceptive methods ”do not protect against HIV and other sexually transmitted infections (STIs)”.

The guideline notes that ”correct and consistent use of condoms should be used where there is a risk of STIs, including HIV”.

WHO also recommends considering offering pre-exposure prophylaxis (PrEP) in settings where the incidence of HIV is above 3 per cent as appropriate.

The updated WHO guideline follows a thorough review of the latest scientific evidence.

It said women should have access to the full range of modern contraceptive methods ”so they can make informed choices around contraceptive choice and their sexual health”.

Highest rates of HIV transmission

The updated recommendations to the WHO guideline, medical eligibility criteria for contraceptive use, stem from a review of the latest evidence conducted by the independent Guideline Development Group convened to inform WHO.

This Group assessed all of the evidence on hormonal contraception and risk of HIV acquisition published since the previous review published in 2016, along with a systematic review of all published evidence on copper-bearing IUDs and HIV risk.

The global recommendations have particular bearing for sub-Saharan Africa, which has the highest rates of HIV transmission and some of the biggest challenges in ensuring women have access to a full range of contraceptive options.

Currently, a quarter of women aged 15–49 in Africa (24 per cent), who want to delay or prevent having children, have limited access to modern contraception. This is the highest unmet need across all WHO regions.

Meanwhile, the Executive Director, Universal Health Coverage/Life Course at WHO, Peter Salama said “Evidence shows that a woman’s risk of HIV should not restrict her contraceptive choice.

“All women should have access to a wide range of options for contraception as well as to HIV prevention and to treatment if needed,” he said.


PT Mag Campaign AD

Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.


TEXT AD: To advertise here . Call Willie +2347088095401...

NEVER MISS A THING AGAIN! Subscribe to our newsletter

* indicates required


Now available on

  Premium Times Android mobile applicationPremium Times iOS mobile applicationPremium Times blackberry mobile applicationPremium Times windows mobile application

All rights reserved. This material and any other material on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from PREMIUM TIMES.